{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:18:42Z","timestamp":1792631922843,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10620-024-08593-5","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T18:02:19Z","timestamp":1726682539000},"page":"3863-3874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vonoprazan vs. Proton Pump Inhibitors for Treatment and Prevention of Gastric and\/or Duodenal Ulcers: A Systematic Review with Meta-Analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Daniel Martin","family":"Simadibrata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Lesmana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Iqbal Adi","family":"Pratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianus Jonathan","family":"Sugiharta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayers Gilberth Ivano","family":"Kalaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzita Diandra Diva","family":"Fadhilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pojsakorn","family":"Danpanichkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari Fahrial","family":"Syam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcellus","family":"Simadibrata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"8593_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12876-022-02130-2","volume":"22","author":"X Xie","year":"2022","unstructured":"Xie X, Ren K, Zhou Z, Dang C, Zhang H. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol. 2022;22:58.","journal-title":"BMC Gastroenterol."},{"key":"8593_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(16)32404-7","volume":"390","author":"A Lanas","year":"2017","unstructured":"Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390:613\u2013624.","journal-title":"Lancet."},{"key":"8593_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.amjmed.2018.12.009","volume":"132","author":"RT Kavitt","year":"2019","unstructured":"Kavitt RT, Lipowska AM, Anyane-Yeboa A, Gralnek IM. Diagnosis and treatment of peptic ulcer disease. The American Journal of Medicine. 2019;132:447\u2013456.","journal-title":"The American Journal of Medicine."},{"key":"8593_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13017-019-0283-9","volume":"15","author":"A Tarasconi","year":"2020","unstructured":"Tarasconi A, Coccolini F, Biffl WL, Tomasoni M, Ansaloni L, Picetti E et al. Perforated and bleeding peptic ulcer: WSES guidelines. World J Emerg Surg. 2020;15:3.","journal-title":"World J Emerg Surg."},{"key":"8593_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4253\/wjge.v4.i1.1","volume":"4","author":"Y Muraki","year":"2012","unstructured":"Muraki Y, Enomoto S, Iguchi M, Fujishiro M, Yahagi N, Ichinose M. Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection. World J Gastrointest Endosc. 2012;4:1\u20138.","journal-title":"World J Gastrointest Endosc."},{"key":"8593_CR6","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/bcp.15103","volume":"88","author":"SK Veettil","year":"2022","unstructured":"Veettil SK, Sadoyu S, Bald EM, Chandran VP, Khuu SAT, Pitak P et al. Association of proton-pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta-analyses of cohort studies and randomised controlled trials. Br J Clin Pharmacol. 2022;88:1551\u20131566.","journal-title":"Br J Clin Pharmacol."},{"key":"8593_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/CEG.S228352","volume":"13","author":"E Marabotto","year":"2020","unstructured":"Marabotto E, Ziola S, Savarino V, Giannini EG, Furnari M, Bodini G et al. Vonoprazan fumarate for the treatment of gastric ulcers: A short review on emerging data. Clin Exp Gastroenterol. 2020;13:99\u2013104.","journal-title":"Clin Exp Gastroenterol."},{"key":"8593_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1087057111421004","volume":"17","author":"M Kondo","year":"2012","unstructured":"Kondo M, Kawamoto M, Hasuoka A, Kajino M, Inatomi N, Tarui N. High-throughput screening of potassium-competitive acid blockers. J Biomol Screen. 2012;17:177\u2013182.","journal-title":"J Biomol Screen."},{"key":"8593_CR9","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1111\/jgh.16017","volume":"37","author":"DM Simadibrata","year":"2022","unstructured":"Simadibrata DM, Syam AF, Lee YY. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37:2217\u20132228.","journal-title":"J Gastroenterol Hepatol."},{"key":"8593_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12664-023-01384-2","volume":"42","author":"S Chandan","year":"2023","unstructured":"Chandan S, Deliwala S, Mohan BP, Ramai D, Dhindsa B, Bapaye J et al. Vonoprazan versus lansoprazole in erosive esophagitis\u2014A systematic review and meta-analysis of randomized controlled trials. Indian J Gastroenterol. 2023;42:475\u2013484.","journal-title":"Indian J Gastroenterol."},{"key":"8593_CR11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/MEG.0000000000001204","volume":"30","author":"V Jaruvongvanich","year":"2018","unstructured":"Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2018;30:1416\u20131421.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"8593_CR12","doi-asserted-by":"publisher","first-page":"e19357","DOI":"10.1097\/MD.0000000000019357","volume":"99","author":"ZY Martin","year":"2020","unstructured":"Martin ZY, Meng CX, Takagi T, Tian YS. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies. Medicine (Baltimore). 2020;99:e19357.","journal-title":"Medicine (Baltimore)."},{"key":"8593_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Reviews. 2021;10:89.","journal-title":"Systematic Reviews."},{"key":"8593_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2229-3485.83221","volume":"2","author":"SK Gupta","year":"2011","unstructured":"Gupta SK. Intention-to-treat concept: A review. Perspect Clin Res. 2011;2:109\u2013112.","journal-title":"Perspect Clin Res."},{"key":"8593_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"HG Gordon","year":"2008","unstructured":"Gordon HG, Andrew DO, Gunn EV, Regina K, Yngve F-Y, Pablo A-C et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924.","journal-title":"BMJ."},{"key":"8593_CR16","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1177\/21925682221110527","volume":"12","author":"JR Dettori","year":"2022","unstructured":"Dettori JR, Norvell DC, Chapman JR. Fixed-effect vs random-effects models for meta-analysis: 3 points to consider. Global Spine J. 2022;12:1624\u20131626.","journal-title":"Global Spine J."},{"key":"8593_CR17","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M. Chapter 10: Analysing data and undertaking meta-analyses| Cochrane Training. Cochrane handbook for systematic reviews of interventions version. 2021"},{"key":"8593_CR18","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.cgh.2006.09.013","volume":"4","author":"IM Gralnek","year":"2006","unstructured":"Gralnek IM, Dulai GS, Fennerty MB, Spiegel BM. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials. Clin Gastroenterol Hepatol. 2006;4:1452\u20131458.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8593_CR19","first-page":"A387","volume":"4","author":"A Koizumi","year":"2016","unstructured":"Koizumi A, Yamashita H, Okada A. Comparison of lansoprazole with vonoprazan for treating post-endoscopic submucosal dissection ulcers. United European Gastroenterology Journal. 2016;4:A387\u2013A388.","journal-title":"United European Gastroenterology Journal."},{"key":"8593_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4253\/wjge.v8.i19.716","volume":"8","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Sato Y, Kohisa J, Watanabe J, Sato H, Mizuno K et al. Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers. World Journal of Gastrointestinal Endoscopy. 2016;8:716\u2013722.","journal-title":"World Journal of Gastrointestinal Endoscopy."},{"key":"8593_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/den.12857","volume":"29","author":"I Tsuchiya","year":"2017","unstructured":"Tsuchiya I, Kato Y, Tanida E, Masui Y, Kato S, Nakajima A et al. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial. Digestive Endoscopy\u202f: Official Journal of the Japan Gastroenterological Endoscopy Society. 2017;29:576\u2013583.","journal-title":"Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society."},{"key":"8593_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00535-018-1487-6","volume":"54","author":"K Hamada","year":"2019","unstructured":"Hamada K, Uedo N, Tonai Y, Arao M, Suzuki S, Iwatsubo T et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study. Journal of Gastroenterology. 2019;54:122\u2013130.","journal-title":"Journal of Gastroenterology."},{"key":"8593_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s10620-018-4948-0","volume":"63","author":"A Hirai","year":"2018","unstructured":"Hirai A, Takeuchi T, Takahashi Y, Kawaguchi S, Ota K, Harada S et al. Comparison of the effects of vonoprazan and lansoprazole for treating endoscopic submucosal dissection-induced artificial ulcers. Digestive Diseases and Sciences. 2018;63:974\u2013981.","journal-title":"Digestive Diseases and Sciences."},{"key":"8593_CR24","doi-asserted-by":"publisher","first-page":"1615092","DOI":"10.1155\/2018\/1615092","volume":"2018","author":"Y Ishii","year":"2018","unstructured":"Ishii Y, Yamada H, Sato T, Sue S, Kaneko H, Irie K et al. Effects of vonoprazan compared with esomeprazole on the healing of artificial postendoscopic submucosal dissection ulcers: a prospective, multicenter, two-arm, randomized controlled trial. Gastroenterology Research and Practice. 2018;2018:1615092.","journal-title":"Gastroenterology Research and Practice."},{"key":"8593_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2169\/internalmedicine.1146-18","volume":"58","author":"T Ichida","year":"2019","unstructured":"Ichida T, Ueyama S, Eto T, Kusano F, Sakai Y. Randomized controlled trial comparing the effects of vonoprazan plus rebamipide and esomeprazole plus rebamipide on gastric ulcer healing induced by endoscopic submucosal dissection. Internal Medicine (Tokyo, Japan). 2019;58:159\u2013166.","journal-title":"Internal Medicine (Tokyo, Japan)."},{"key":"8593_CR26","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1177\/0300060519828514","volume":"47","author":"H Komori","year":"2019","unstructured":"Komori H, Ueyama H, Nagahara A, Akazawa Y, Takeda T, Matsumoto K et al. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia. Journal of International Medical Research. 2019;47:1441\u20131452.","journal-title":"Journal of International Medical Research."},{"key":"8593_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3164\/jcbn.20-143","volume":"68","author":"H Ban","year":"2021","unstructured":"Ban H, Inatomi O, Murata M, Otsuka T, Oi M, Matsumoto H et al. Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study. Journal of Clinical Biochemistry and Nutrition. 2021;68:259\u2013263.","journal-title":"Journal of Clinical Biochemistry and Nutrition."},{"key":"8593_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12876-021-01822-5","volume":"21","author":"D Kawai","year":"2021","unstructured":"Kawai D, Takenaka R, Ishiguro M, Okanoue S, Gotoda T, Kono Y et al. Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial. BMC Gastroenterology. 2021;21:236.","journal-title":"BMC Gastroenterology."},{"key":"8593_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/apt.13876","volume":"45","author":"H Miwa","year":"2017","unstructured":"Miwa H, Uedo N, Watari J, Mori Y, Sakurai Y, Takanami Y et al. Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers\u2014results from two phase 3, non-inferiority randomised controlled trials. Alimentary Pharmacology and Therapeutics 2017;45:240\u2013252.","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"8593_CR30","unstructured":"NCT03050307. Comparison of TAK-438 (Vonoprazan) to lansoprazole in the treatment of gastric ulcer participants with or without helicobacter pylori infection. 2017. https:\/\/clinicaltrials.gov\/study\/NCT03050307."},{"key":"8593_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/jgh.15837","volume":"37","author":"X Hou","year":"2022","unstructured":"Hou X, Meng F, Wang J, Sha W, Chiu C-T, Chung WC et al. Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients. Journal of Gastroenterology and Hepatology. 2022;37:1275\u20131283.","journal-title":"Journal of Gastroenterology and Hepatology."},{"key":"8593_CR32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/gutjnl-2017-314010","volume":"67","author":"Y Mizokami","year":"2018","unstructured":"Mizokami Y, Oda K, Funao N, Nishimura A, Soen S, Kawai T et al. Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study. Gut. 2018;67:1042\u20131051.","journal-title":"Gut."},{"key":"8593_CR33","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/gutjnl-2017-314852","volume":"67","author":"T Kawai","year":"2017","unstructured":"Kawai T, Oda K, Funao N, Nishimura A, Matsumoto Y, Mizokami Y et al. Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study. Gut. 2017;67:1033\u20131041.","journal-title":"Gut."},{"key":"8593_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015860","volume":"98","author":"H Kang","year":"2019","unstructured":"Kang H, Kim BJ, Choi G, Kim JG. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis. Medicine (Baltimore). 2019;98:e15860.","journal-title":"Medicine (Baltimore)."},{"key":"8593_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/1751-2980.12813","volume":"20","author":"C Liu","year":"2019","unstructured":"Liu C, Feng BC, Zhang Y, Li LX, Zuo XL, Li YQ. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis. J Dig Dis. 2019;20:503\u2013511.","journal-title":"J Dig Dis."},{"key":"8593_CR36","first-page":"168","volume":"115","author":"T Miao","year":"2023","unstructured":"Miao T, Zhang Y, Bai L, Yang X, Wen X. Vonoprazan vs. lansoprazole for the treatment of endoscopic submucosal dissection induced gastric ulcer: a systematic review and meta-analysis. Rev Esp Enferm Dig. 2023;115:168\u2013174.","journal-title":"Rev Esp Enferm Dig."},{"key":"8593_CR37","unstructured":"\u9648\u65cb, \u5f90\u68a6\u5a77, \u6587\u5251\u6ce2. \u65b0\u578b\u6291\u9178\u5242\u6c83\u8bfa\u62c9\u8d5e\u4e0e\u4f20\u7edf PPIs \u9884\u9632\u80c3 ESD \u672f\u540e\u8fdf\u53d1\u6027\u51fa\u8840\u548c\u4fc3\u8fdb\u4eba\u9020\u6e83\u75a1\u6108\u5408\u6bd4\u8f83\u7684 Meta \u5206\u6790: 2474 \u4f8b. \u4e16\u754c\u534e\u4eba\u6d88\u5316\u6742\u5fd7. 2020;28(24):1249\u20131260."},{"key":"8593_CR38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1056\/NEJMsb1901642","volume":"382","author":"R Collins","year":"2020","unstructured":"Collins R, Bowman L, Landray M, Peto R. The magic of randomization versus the myth of real-world evidence. New England Journal of Medicine. 2020;382:674\u2013678.","journal-title":"New England Journal of Medicine."},{"key":"8593_CR39","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00535-021-01781-4","volume":"56","author":"H Abe","year":"2021","unstructured":"Abe H, Hatta W, Ogata Y, Koike T, Saito M, Jin X et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J Gastroenterol. 2021;56:640\u2013650.","journal-title":"J Gastroenterol."},{"key":"8593_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4253\/wjge.v3.i3.49","volume":"3","author":"HC Cheng","year":"2011","unstructured":"Cheng HC, Sheu BS. Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits. World J Gastrointest Endosc. 2011;3:49\u201356.","journal-title":"World J Gastrointest Endosc."},{"key":"8593_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5056\/jnm18029","volume":"24","author":"T Oshima","year":"2018","unstructured":"Oshima T, Miwa H. Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases. J Neurogastroenterol Motil. 2018;24:334\u2013344.","journal-title":"J Neurogastroenterol Motil."},{"key":"8593_CR42","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s10620-023-08233-4","volume":"69","author":"H An","year":"2024","unstructured":"An H, Chen J, Li S, Chen A. Pantoprazole and vonoprazan performed well in preventing peptic ulcer recurrence in low-dose aspirin users. Dig Dis Sci. 2024;69:670\u2013682. https:\/\/doi.org\/10.1007\/s10620-023-08233-4","journal-title":"Dig Dis Sci."},{"key":"8593_CR43","doi-asserted-by":"publisher","first-page":"1304552","DOI":"10.3389\/fphar.2023.1304552","volume":"14","author":"Y Dong","year":"2024","unstructured":"Dong Y, Xu H, Zhang Z, Zhou Z, Zhang Q. Comparative efficiency and safety of potassium competitive acid blockers versus lansoprazole in peptic ulcer: a systematic review and meta-analysis. Frontiers in Pharmacology. 2024;14:1304552.","journal-title":"Frontiers in Pharmacology."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08593-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T18:07:40Z","timestamp":1729274860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08593-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["8593"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08593-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"6 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}